Overview

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if androgen deprivation therapy in men with prostate cancer increases hepatic fat content and changes visceral/subcutaneous fat distribution.
Phase:
Phase 4
Details
Lead Sponsor:
Herlev Hospital
Treatments:
Androgens
Triptorelin Pamoate